FREE SHIPPING over $40
OVER 9000 FIVE-STAR REVIEWS
5% OFF ALL SUBSCRIPTIONS
100% HAPPINESS GUARANTEE
Analyze Diet
0
Home / Equine Research Bank / Appl Environ Microbiol / Clostridioides difficile in feral horse populations in Austr...
Applied and environmental microbiology2025; 91(5); e0211424; doi: 10.1128/aem.02114-24

Clostridioides difficile in feral horse populations in Australia.

Abstract: Clostridioides difficile is a known cause of diarrhea and colitis in human and non-human animals. While C. difficile is regularly isolated from domesticated horses, little is known about its prevalence in wild or feral populations. In Australia, the horse population encompasses a mix of both domesticated and feral animals, with the feral population of 400,000 estimated to be the largest in the world. This study investigated the presence and characteristics of C. difficile in Australian feral horses and evaluated their potential as a source or reservoir of C. difficile in the wider community. Fecal samples (n = 380) were collected from free-roaming feral horses from five Australian jurisdictions and cultured for C. difficile. Isolates were characterized by PCR ribotyping and toxin profiling. Antimicrobial susceptibility testing was performed for fidaxomicin, vancomycin, metronidazole, rifaximin, clindamycin, erythromycin, amoxicillin-clavulanate, moxifloxacin, meropenem, and tetracycline. C. difficile was isolated from 45 of the 380 samples (11.8%)-one-third of that seen in recent studies on Australian domesticated horses but consistent with wild animal species worldwide. Forty ribotypes (RTs) were identified, 28 of which (70%) were novel; other RTs had been previously reported in humans, livestock, and soils. Eighteen toxigenic C. difficile strains were isolated, of which eight contain binary toxin genes. Strains were largely susceptible to the antimicrobial agents tested. This investigation provides preliminary information on C. difficile in feral horses in Australia and allows a comparison with their domestic counterparts. The findings support the hypothesis that all horse feces represent a potential source of C. difficile in the community. Objective: Clostridioides difficile poses an ongoing threat to healthcare in the community, with increasing evidence of transmission outside the hospital setting. In keeping with a One Health model of dispersion, investigations into this microorganism within the wider environment are vital to understanding this evolving epidemiology. Australia has the biggest population of feral horses in the world, and this study of C. difficile in feral horses provides insight into the role of non-domesticated animals in the dissemination of C. difficile. Examination of prevalence and characterization of isolates provides a baseline for evaluating the effect of antimicrobials and other factors associated with domestication on equine C. difficile infection.
Get Full Text
Publication Date: 2025-04-02 PubMed ID: 40172204PubMed Central: PMC12093960DOI: 10.1128/aem.02114-24Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
LinkedInCopy
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research paper is a study on the prevalence and characteristics of Clostridioides difficile (C. difficile) in feral horse populations in Australia, in comparison to their domestic counterparts, and their potential role in the spreading of C. difficile in the community.

Objective of the Study

  • The primary goal was to investigate the presence and characteristics of C. difficile in feral horses in Australia and to contrast this with the disease’s presence in domestic horses.
  • Another aspect of the study aimed to understand the potential role the feral horses might play in transmission of C. difficile within the community.

Methodology

  • The researchers collected fecal samples from 380 free-roaming feral horses across five Australian jurisdictions and cultured these for C. difficile.
  • The isolated C. difficile was characterized using PCR ribotyping and toxin profiling.
  • Lastly, they conducted antimicrobial susceptibility testing against several drugs to see the resistance patterns of the isolated strains.

Findings

  • Out of 380 samples, 45 (11.8%) were found positive for C. difficile. This prevalence is one third of what was seen in domesticated horses previously but aligns with the prevalence among wild animal species globally.
  • A total of 40 ribotypes (RTs) were identified; out of which 28 (70%) were novel, and others had been reported previously in humans, livestock, and soils indicating a potential transmission path.
  • 18 toxigenic C. difficile strains were isolated, eight of which contained binary toxin genes.
  • The majority of the strains were seen to be susceptible to the tested antimicrobials which can be useful for treatment in case of infections.

Conclusion

  • The study provides initial data on the C. difficile prevalence in feral horses of Australia and emphasizes the role of feces from all horse types as a potential source of this bacterium in the community.
  • The results also support the notion of the One Health model, highlighting feral horses’ potential role in disseminating this bacteria beyond a hospital setting.
  • The findings offer a basis to understand the effects of antimicrobials and other factors related to domestication on equine C. difficile infection.

Cite This Article

APA
Hain-Saunders NMR, Knight DR, Harvey A, Bruce M, Hampson BA, Riley TV. (2025). Clostridioides difficile in feral horse populations in Australia. Appl Environ Microbiol, 91(5), e0211424. https://doi.org/10.1128/aem.02114-24

Publication

Applied and environmental microbiology
ISSN: 1098-5336
NlmUniqueID: 7605801
Country: United States
Language: English
Volume: 91
Issue: 5
Pages: e0211424

Researcher Affiliations

Hain-Saunders, Natasza M R
  • Biosecurity and One Health Research Centre, Harry Butler Institute, Murdoch University, Murdoch, Western Australia, Australia.
Knight, Daniel R
  • Department of Microbiology, PathWest Laboratory Medicine, Queen Elizabeth II Medical Centre, Nedlands, Western Australia, Australia.
  • School of Biomedical Sciences, The University of Western Australia, Queen Elizabeth II Medical Centre, Nedlands, Western Australia, Australia.
Harvey, Andrea
  • Centre for Compassionate Conservation, School of Life Sciences, Faculty of Science, University of Technology Sydney, Broadway, New South Wales, Australia.
Bruce, Mieghan
  • Biosecurity and One Health Research Centre, Harry Butler Institute, Murdoch University, Murdoch, Western Australia, Australia.
  • School of Veterinary Medicine, Murdoch University, Murdoch, Western Australia, Australia.
Hampson, Brian A
  • Independent Researcher, Brisbane, Australia.
Riley, Thomas V
  • Department of Microbiology, PathWest Laboratory Medicine, Queen Elizabeth II Medical Centre, Nedlands, Western Australia, Australia.
  • School of Biomedical Sciences, The University of Western Australia, Queen Elizabeth II Medical Centre, Nedlands, Western Australia, Australia.
  • School of Medical and Health Sciences, Edith Cowan University, Joondalup, Western Australia, Australia.

MeSH Terms

  • Animals
  • Horses / microbiology
  • Clostridioides difficile / isolation & purification
  • Clostridioides difficile / genetics
  • Clostridioides difficile / drug effects
  • Clostridioides difficile / classification
  • Australia / epidemiology
  • Clostridium Infections / veterinary
  • Clostridium Infections / epidemiology
  • Clostridium Infections / microbiology
  • Horse Diseases / microbiology
  • Horse Diseases / epidemiology
  • Anti-Bacterial Agents / pharmacology
  • Feces / microbiology
  • Animals, Wild / microbiology
  • Ribotyping
  • Microbial Sensitivity Tests

Grant Funding

  • APP1138257 / DHAC | National Health and Medical Research Council (NHMRC)

Conflict of Interest Statement

The authors declare no conflict of interest.

References

This article includes 62 references
  1. Båverud V, Gustafsson A, Franklin A, Aspán A, Gunnarsson A. Clostridium difficile: prevalence in horses and environment, and antimicrobial susceptibility.. Equine Vet J 35:465–471.
    doi: 10.2746/042516403775600505pubmed: 12875324google scholar: lookup
  2. Khanna S, Pardi DS, Aronson SL, Kammer PP, Orenstein R, St Sauver JL, Harmsen WS, Zinsmeister AR. The epidemiology of community-acquired Clostridium difficile infection: a population-based study.. Am J Gastroenterol 107:89–95.
    doi: 10.1038/ajg.2011.398pmc: PMC3273904pubmed: 22108454google scholar: lookup
  3. Slimings C, Armstrong P, Beckingham WD, Bull AL, Hall L, Kennedy KJ, Marquess J, McCann R, Menzies A, Mitchell BG, Richards MJ, Smollen PC, Tracey L, Wilkinson IJ, Wilson FL, Worth LJ, Riley TV. Increasing incidence of Clostridium difficile infection, Australia, 2011-2012.. Med J Aust 200:272–276.
    doi: 10.5694/mja13.11153pubmed: 24641152google scholar: lookup
  4. Knight DR, Kullin B, Androga GO, Barbut F, Eckert C, Johnson S, Spigaglia P, Tateda K, Tsai P-J, Riley TV. Evolutionary and genomic insights into Clostridioides difficile sequence type 11: a diverse zoonotic and antimicrobial-resistant lineage of global one health importance.. MBio 10:e00446-19.
    doi: 10.1128/mBio.00446-19pmc: PMC6469969pubmed: 30992351google scholar: lookup
  5. Australian Commission on Safety and Quality in Health Care. Clostridioides difficile infection data snapshot report: 2020 and 2021.. Australian Commission on Safety and Quality in Health Care 2023.
  6. Arroyo LG, Weese JS, Staempfli HR. Experimental Clostridium difficile enterocolitis in foals.. J Vet Intern Med 18:734–738.
    doi: 10.1111/j.1939-1676.2004.tb02613.xpubmed: 15515592google scholar: lookup
  7. Bland SD. Equine colic: a review of the equine hindgut and colic.. Vet Sci Develop 6.
    doi: 10.4081/vsd.2016.6223google scholar: lookup
  8. Arroyo LG, Staempfli H, Weese JS. Molecular analysis of Clostridium difficile isolates recovered from horses with diarrhea.. Vet Microbiol 120:179–183.
    doi: 10.1016/j.vetmic.2006.10.013pubmed: 17112686google scholar: lookup
  9. Weese JS, Toxopeus L, Arroyo L. Clostridium difficile associated diarrhoea in horses within the community: predictors, clinical presentation and outcome.. Equine Vet J 38:185–188.
    doi: 10.2746/042516406776563369pubmed: 16536390google scholar: lookup
  10. Uchida-Fujii E, Niwa H, Senoh M, Kato H, Kinoshita Y, Mita H, Ueno T. Clostridioides difficile infection in thoroughbred horses in Japan from 2010 to 2021.. Sci Rep 13:13099.
    doi: 10.1038/s41598-023-40157-xpmc: PMC10421859pubmed: 37567893google scholar: lookup
  11. Hain-Saunders NMR, Knight DR, Bruce M, Byrne D, Riley TV. Genomic analysis of Clostridioides difficile recovered from horses in western australia.. Microorganisms 11:1743.
    doi: 10.3390/microorganisms11071743pmc: PMC10386058pubmed: 37512915google scholar: lookup
  12. Dobbie WR, Berman D, Braysher M. Managing vertebrate pests: feral horses.. 1993.
  13. Dawson MJ, Lane C, Saunders G. Proceedings of the National Feral Horse Management Workshop August 2006.. .
  14. Department of Sustainability, Environment, Water, Population and Communities. Feral horse (Equus caballus) and feral donkey (Equus asinus).. 2016.
  15. Csurhes S, Paroz G, Markula A. Ferel horses: invasive animal risk assessment.. 2016.
  16. Weese JS, Salgado-Bierman F, Rupnik M, Smith DA, van Coeverden de Groot P. Clostridium (Clostridioides) difficile shedding by polar bears (Ursus maritimus) in the Canadian Arctic.. Anaerobe 57:35–38.
    doi: 10.1016/j.anaerobe.2019.03.013pubmed: 30880150google scholar: lookup
  17. Bandelj P, Knapič T, Rousseau J, Podgorelec M, Presetnik P, Vengust M, Scott Weese J. Clostridioides difficile in bat guano.. Comp Immunol Microbiol Infect Dis 65:144–147.
    doi: 10.1016/j.cimid.2019.05.016pubmed: 31300105google scholar: lookup
  18. Bandelj P, Blagus R, Briski F, Frlic O, Vergles Rataj A, Rupnik M, Ocepek M, Vengust M. Identification of risk factors influencing Clostridium difficile prevalence in middle-size dairy farms.. Vet Res 47:41.
    doi: 10.1186/s13567-016-0326-0pmc: PMC4788955pubmed: 26968527google scholar: lookup
  19. Ozaki E, Kato H, Kita H, Karasawa T, Maegawa T, Koino Y, Matsumoto K, Takada T, Nomoto K, Tanaka R, Nakamura S. Clostridium difficile colonization in healthy adults: transient colonization and correlation with enterococcal colonization.. J Med Microbiol 53:167–172.
    doi: 10.1099/jmm.0.05376-0pubmed: 14729940google scholar: lookup
  20. Orenstein R, Patron RL, Seville MT. Why does Clostridium difficile infection recur?. J Am Osteopath Assoc 119:322–326.
    doi: 10.7556/jaoa.2019.054pubmed: 31034070google scholar: lookup
  21. Thean S, Elliott B, Riley TV. Clostridium difficile in horses in Australia – a preliminary study.. J Med Microbiol 60:1188–1192.
    doi: 10.1099/jmm.0.030908-0pubmed: 21436371google scholar: lookup
  22. Weese JS, Staempfli HR, Prescott JF. A prospective study of the roles of Clostridium difficile and enterotoxigenic Clostridium perfringens in equine diarrhoea.. Equine Vet J 33:403–409.
    doi: 10.2746/042516401776249534pubmed: 11469775google scholar: lookup
  23. Shaughnessy MK, Snider T, Sepulveda R, Boxrud D, Cebelinski E, Jawahir S, Holzbauer S, Johnston BD, Smith K, Bender JB, Thuras P, Diez-Gonzalez F, Johnson JR. Prevalence and molecular characteristics of Clostridium difficile in retail meats, food-producing and companion animals, and humans in minnesota.. J Food Prot 81:1635–1642.
    doi: 10.4315/0362-028X.JFP-18-104pubmed: 30198756google scholar: lookup
  24. Keel MK, Songer JG. The comparative pathology of Clostridium difficile-associated disease.. Vet Pathol 43:225–240.
    doi: 10.1354/vp.43-3-225pubmed: 16672570google scholar: lookup
  25. Schoster A, Staempfli HR. Epidemiology and antimicrobial resistance in Clostridium difficile with special reference to the horse.. Curr Clin Micro Rpt 3:32–41.
    doi: 10.1007/s40588-016-0029-3google scholar: lookup
  26. Slimings C, Riley TV. Antibiotics and hospital-acquired Clostridium difficile infection: update of systematic review and meta-analysis.. J Antimicrob Chemother 69:881–891.
    doi: 10.1093/jac/dkt477pubmed: 24324224google scholar: lookup
  27. Kauter A, Epping L, Semmler T, Antao E-M, Kannapin D, Stoeckle SD, Gehlen H, Lübke-Becker A, Günther S, Wieler LH, Walther B. The gut microbiome of horses: current research on equine enteral microbiota and future perspectives.. Anim Microbiome 1:14.
    doi: 10.1186/s42523-019-0013-3pmc: PMC7807895pubmed: 33499951google scholar: lookup
  28. Denève C, Deloménie C, Barc M-C, Collignon A, Janoir C. Antibiotics involved in Clostridium difficile-associated disease increase colonization factor gene expression.. J Med Microbiol 57:732–738.
    doi: 10.1099/jmm.0.47676-0pubmed: 18480330google scholar: lookup
  29. Drummond LJ, Smith DGE, Poxton IR. Effects of sub-MIC concentrations of antibiotics on growth of and toxin production by Clostridium difficile.. J Med Microbiol 52:1033–1038.
    doi: 10.1099/jmm.0.05387-0pubmed: 14614060google scholar: lookup
  30. Magistrali CF, Maresca C, Cucco L, Bano L, Drigo I, Filippini G, Dettori A, Broccatelli S, Pezzotti G. Prevalence and risk factors associated with Clostridium difficile shedding in veal calves in Italy.. Anaerobe 33:42–47.
    doi: 10.1016/j.anaerobe.2015.01.010pubmed: 25638401google scholar: lookup
  31. Rodriguez C, Taminiau B, Brévers B, Avesani V, Van Broeck J, Leroux AA, Amory H, Delmée M, Daube G. Carriage and acquisition rates of Clostridium difficile in hospitalized horses, including molecular characterization, multilocus sequence typing and antimicrobial susceptibility of bacterial isolates.. Vet Microbiol 172:309–317.
    doi: 10.1016/j.vetmic.2014.05.013pubmed: 24894133google scholar: lookup
  32. Harlow BE, Lawrence LM, Flythe MD. Diarrhea-associated pathogens, lactobacilli and cellulolytic bacteria in equine feces: responses to antibiotic challenge.. Vet Microbiol 166:225–232.
    doi: 10.1016/j.vetmic.2013.05.003pubmed: 23769300google scholar: lookup
  33. Richards S, Bailey KE, Scarborough R, Gilkerson JR, Browning GF, Hur B, Ierardo J, Awad M, Chay R, Hardefeldt LY. Cross-sectional evaluation of a large-scale antimicrobial stewardship trial in Australian companion animal practices.. Vet Rec 194:e3268.
    doi: 10.1002/vetr.3268pubmed: 37518680google scholar: lookup
  34. Hardefeldt LY, Gilkerson JR, Billman-Jacobe H, Stevenson MA, Thursky K, Bailey KE, Browning GF. Barriers to and enablers of implementing antimicrobial stewardship programs in veterinary practices.. J Vet Intern Med 32:1092–1099.
    doi: 10.1111/jvim.15083pmc: PMC5980358pubmed: 29573053google scholar: lookup
  35. Medina-Torres CE, Weese JS, Staempfli HR. Prevalence of Clostridium difficile in horses.. Vet Microbiol 152:212–215.
    doi: 10.1016/j.vetmic.2011.04.012pubmed: 21570780google scholar: lookup
  36. Knight DR, Squire MM, Riley TV. Nationwide surveillance study of Clostridium difficile in Australian neonatal pigs shows high prevalence and heterogeneity of PCR ribotypes.. Appl Environ Microbiol 81:119–123.
    doi: 10.1128/AEM.03032-14pmc: PMC4272713pubmed: 25326297google scholar: lookup
  37. Brouwer MSM, Roberts AP, Hussain H, Williams RJ, Allan E, Mullany P. Horizontal gene transfer converts non-toxigenic Clostridium difficile strains into toxin producers.. Nat Commun 4:2601.
    doi: 10.1038/ncomms3601pmc: PMC3826655pubmed: 24131955google scholar: lookup
  38. Elliott B, Dingle KE, Didelot X, Crook DW, Riley TV. The complexity and diversity of the pathogenicity locus in Clostridium difficile clade 5.. Genome Biol Evol 6:3159–3170.
    doi: 10.1093/gbe/evu248pmc: PMC4986448pubmed: 25381663google scholar: lookup
  39. Candel-Pérez C, Ros-Berruezo G, Martínez-Graciá C. A review of Clostridioides [Clostridium] difficile occurrence through the food chain.. Food Microbiol 77:118–129.
    doi: 10.1016/j.fm.2018.08.012pubmed: 30297042google scholar: lookup
  40. He M, Miyajima F, Roberts P, Ellison L, Pickard DJ, Martin MJ, Connor TR, Harris SR, Fairley D, Bamford KB. Emergence and global spread of epidemic healthcare-associated Clostridium difficile.. Nat Genet 45:109–113.
    doi: 10.1038/ng.2478pmc: PMC3605770pubmed: 23222960google scholar: lookup
  41. Marvaud JC, Quevedo-Torres S, Eckert C, Janoir C, Barbut F. Virulence of new variant strains of Clostridium difficile producing only toxin A or binary toxin in the hamster model.. New Microbes New Infect 32:100590.
    doi: 10.1016/j.nmni.2019.100590pmc: PMC6734109pubmed: 31516714google scholar: lookup
  42. Monot M, Eckert C, Lemire A, Hamiot A, Dubois T, Tessier C, Dumoulard B, Hamel B, Petit A, Lalande V, Ma L, Bouchier C, Barbut F, Dupuy B. Clostridium difficile: new insights into the evolution of the pathogenicity locus.. Sci Rep 5:15023.
    doi: 10.1038/srep15023pmc: PMC4597214pubmed: 26446480google scholar: lookup
  43. Keessen EC, Hopman NEM, van Leengoed LAMG, van Asten AJAM, Hermanus C, Kuijper EJ, Lipman LJA. Evaluation of four different diagnostic tests to detect Clostridium difficile in piglets.. J Clin Microbiol 49:1816–1821.
    doi: 10.1128/JCM.00242-11pmc: PMC3122649pubmed: 21411571google scholar: lookup
  44. Fathy M, Abdel-Moein KA, Osman WA, Erfan AM, Prince A, Hafez AA, Eldin Mahmoud H, Mosallam TE, Samir A. Performance of different laboratory methods for detection of Clostridium difficile in animal samples.. Adv Anim Vet Sci 9:132–136.
    doi: 10.17582/journal.aavs/2021/9.1.132.136google scholar: lookup
  45. McDonald LC, Gerding DN, Johnson S, Bakken JS, Carroll KC, Coffin SE, Dubberke ER, Garey KW, Gould CV, Kelly C, Loo V, Shaklee Sammons J, Sandora TJ, Wilcox MH. Clinical practice guidelines for Clostridium difficile infection in adults and children: 2017 Update by the infectious diseases society of America (IDSA) and society for healthcare epidemiology of America (SHEA).. Clin Infect Dis 66:e1–e48.
    doi: 10.1093/cid/cix1085pmc: PMC6018983pubmed: 29462280google scholar: lookup
  46. Zakia LS, Arroyo LG, Gomez DE, Boerlin P, Surette MG, Lillie BN. Postmortem examination of equids >1-year-old with enterotyphlocolitis in Ontario: a retrospective descriptive study.. J Vet Diagn Invest 35:350–354.
    doi: 10.1177/10406387231176229pmc: PMC10331376pubmed: 37204051google scholar: lookup
  47. Medina-Torres CE, Weese JS, Staempfli HR. Validation of a commercial enzyme immunoassay for detection of Clostridium difficile toxins in feces of horses with acute diarrhea.. J Vet Intern Med 24:628–632.
    doi: 10.1111/j.1939-1676.2010.00506.xpubmed: 20384955google scholar: lookup
  48. Moono P, Lim SC, Riley TV. High prevalence of toxigenic Clostridium difficile in public space lawns in Western Australia.. Sci Rep 7:41196.
    doi: 10.1038/srep41196pmc: PMC5286503pubmed: 28145453google scholar: lookup
  49. Lim SC, Androga GO, Knight DR, Moono P, Foster NF, Riley TV. Antimicrobial susceptibility of Clostridium difficile isolated from food and environmental sources in Western Australia.. Int J Antimicrob Agents 52:411–415.
    doi: 10.1016/j.ijantimicag.2018.05.013pubmed: 29802886google scholar: lookup
  50. Cellier M, Halimi D, Orenga S. Use of a beta-glucosidase activator for the detection and/or identification of C. difficile.. US patent 20130137126 A1.
  51. Connor MC, Fairley DJ, McKenna JP, Marks NJ, McGrath JW. Clostridium difficile ribotype 023 lacks the ability to hydrolyze esculin, leading to false-negative results on chromogenic agar.. J Clin Microbiol 54:1404–1405.
    doi: 10.1128/JCM.00234-16pmc: PMC4844706pubmed: 26962090google scholar: lookup
  52. Reigadas E, Alcalá L, Marín M, Martín A, Bouza E. C. difficile PCR-ribotype 023 might go undetected when using chromId C. difficile agar.. Anaerobe 44:34–35.
    doi: 10.1016/j.anaerobe.2017.01.008pubmed: 28108388google scholar: lookup
  53. Shivaperumal N, Knight DR, Imwattana K, Androga GO, Chang BJ, Riley TV. Esculin hydrolysis negative and TcdA-only producing strains of Clostridium (Clostridioides) difficile from the environment in Western Australia.. J Appl Microbiol 133:1183–1196.
    doi: 10.1111/jam.15500pmc: PMC9544920pubmed: 35184359google scholar: lookup
  54. Wickramage I, Spigaglia P, Sun X. Mechanisms of antibiotic resistance of Clostridioides difficile.. J Antimicrob Chemother 76:3077–3090.
    doi: 10.1093/jac/dkab231pmc: PMC8598299pubmed: 34297842google scholar: lookup
  55. Centers for Disease Control and Prevention. Antibiotic resistance threats in the United States.. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention 2019.
    doi: 10.15620/cdc:82532google scholar: lookup
  56. Harvey AM, Meggiolaro MN, Hall E, Watts ET, Ramp D, Šlapeta J. Wild horse populations in south-east Australia have a high prevalence of Strongylus vulgaris and may act as a reservoir of infection for domestic horses.. Int J Parasitol Parasites Wildl 8:156–163.
    doi: 10.1016/j.ijppaw.2019.01.008pmc: PMC6378629pubmed: 30815358google scholar: lookup
  57. Lim SC, Foster NF, Elliott B, Riley TV. High prevalence of Clostridium difficile on retail root vegetables, Western Australia.. J Appl Microbiol 124:585–590.
    doi: 10.1111/jam.13653pubmed: 29193458google scholar: lookup
  58. Clinical and Laboratory Standards Institute. Methods for antimicrobial susceptibility testing of anaerobic bacteria.. Clinical and Laboratory Standards Institute 7th ed. 2011.
  59. The European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters, Version 13.0.. 2023.
  60. European Medicines Agency. Assessment report, Dificlir fidaxomicin EMA/857570/2011.. EMA, European Union 2011.
  61. O’Connor JR, Galang MA, Sambol SP, Hecht DW, Vedantam G, Gerding DN, Johnson S. Rifampin and rifaximin resistance in clinical isolates of Clostridium difficile.. Antimicrob Agents Chemother 52:2813–2817.
    doi: 10.1128/AAC.00342-08pmc: PMC2493101pubmed: 18559647google scholar: lookup
  62. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; twenty-third informational supplement.. Clinical and Laboratory Standards Institute M100-S23 2013.
Subscribe to our newsletter
Join 99,344 horse owners like you who receive our email updates on horse health and nutrition.